Start for free
Start for free
BM

BioFund Management

Europe, Southern Finland, Finland, Helsinki

Description

BioFund Management is a a pan-Nordic life sciences management company.

Investor Profile

BioFund Management has made 12 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series Unknown (58%)
  • Series B (17%)
  • Series C (17%)
  • Series E (8%)

Country Focus

  • Canada (33%)
  • Finland (25%)
  • United States (17%)
  • Switzerland (8%)
  • Germany (8%)
  • Sweden (8%)

Industry Focus

  • Biotechnology
  • Genetics
  • Life Science
  • Medical Device
  • Biopharma
  • Health Care
  • Therapeutics
  • Health Diagnostics
  • Pharmaceutical
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioFund Management frequently co-invest with?

HBM Healthcare Investments
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 3
CA
Carnegie Asset Management
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Daiwa SMBC Capital
Daiwa SMBC Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
MF
MVI Finance
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2
AC
Apothecary Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
CB
Co-Investments: 1
Sitra
Sitra
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 2
Astellas Pharma
Astellas Pharma
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Brookside Capital
Brookside Capital
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by BioFund Management?

Genizon BioSciences

Montreal, Quebec, Canada

Genizon Biosciences discovers genes and biomarkers in common diseases using genome-wide association studies.

BiotechnologyGeneticsLife ScienceMedical Device
Series EJan 1, 2008
Amount Raised: $30,810,000
FIT Biotech

Tampere, Western Finland, Finland

FIT Biotech develops GTU technologies and product applications in DNA vaccination and immunogene therapies.

BiotechnologyGeneticsHealth Care
Series UnknownJun 29, 2006
Amount Raised: $6,045,195
Cellartis

Göteborg, Vastra Gotaland, Sweden

Cellartis develops human embryonic stem cells and technology for drug discovery research, toxicity testing and regenerative medicine.

Biotechnology
Series UnknownDec 13, 2005
Amount Raised: $9,553,414
SpinX

Geneva, Geneve, Switzerland

SpinX designs and develops products which exploit its innovative adaptive microfludics technology.

BiotechnologyHealth DiagnosticsLife ScienceMedical DeviceRobotics
Series BSep 6, 2005
Amount Raised: $12,481,449
Hyglos

Bernried, Baden-Wurttemberg, Germany

Hyglos GmbH is a biotech company which develops bacteriophage-derived recombinant proteins for detection and removal of harmful bacteria.

BiopharmaBiotechnologyDeveloper PlatformMedical
Series CAug 23, 2005
Amount Raised: $8,990,000
Ipsat Therapies

Helsinki, Southern Finland, Finland

Ipsat Therapies is a biotechnology company, developing products for the prevention of antibiotic-associated diarrhea and infections. 

BiotechnologyHealth DiagnosticsTherapeutics
Series CApr 3, 2005
Amount Raised: $9,020,000
FibroGen

San Francisco, California, United States

FibroGen uses its expertise in CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.

BiopharmaBiotechnologyHealth CareTherapeutics
Series UnknownFeb 17, 2005
Amount Raised: $100,000,000
Genizon BioSciences

Montreal, Quebec, Canada

Genizon Biosciences discovers genes and biomarkers in common diseases using genome-wide association studies.

BiotechnologyGeneticsLife ScienceMedical Device
Series BDec 13, 2004
Amount Raised: $9,043,138
Genizon BioSciences

Montreal, Quebec, Canada

Genizon Biosciences discovers genes and biomarkers in common diseases using genome-wide association studies.

BiotechnologyGeneticsLife ScienceMedical Device
Series UnknownJan 7, 2004
Amount Raised: $8,655,334
Galileo Genomics

Montreal, Quebec, Canada

Galileo genomics is a Montreal-based private genetics company that conducts research in Quebecers of French descent using cutting-edge.

GeneticsMedicalPharmaceuticalTherapeutics
Series UnknownAug 14, 2002
Amount Raised: $6,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator